The Clorox CompanyEarnings beat and GOJO acquisition boost outlook, driving stock up.

Clorox shares have climbed 13.1% over the past month as investors digest the company's fiscal fourth-quarter results and fiscal 2027 outlook. The company reported adjusted earnings of $1.66 per share, beating the Zacks Consensus Estimate of $1.64, while sales of $1.95 billion also topped expectations despite a 2% year-over-year decline. Management projects fiscal 2027 net sales growth of 13-14%, including about 9.5 points from the GOJO acquisition, and adjusted earnings per share of $5.70 to $6.00. However, profitability remains a concern, with fiscal 2026 gross margin falling 290 basis points to 42.3% and inflation expected to exceed $200 million, more than double the historical range. The Zacks Consensus Estimate for fiscal 2027 earnings has declined 3.8% in the past four weeks to $5.82 per share, and the stock currently carries a Zacks Rank #4 (Sell).
The Clorox CompanyEarnings beat and GOJO acquisition boost outlook, driving stock up.
Church & Dwight Company Inc
Procter & Gamble Company